Licensing opportunity from NIH: inhibitory and immunoblotting MAb specific for P-450 2A6 Jan. 26, 1999
Novel, synthetic ultrasound contrast agent for echocardiography advances to clinical trials Jan. 15, 1999
Excellent clinical results reported for ID Biomedical's rapid MRSA test; February filing announced Jan. 13, 1999
RSS